• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 ATTUNE RP TIB BASE SZ 2 CEM; ATTUNE IMPLANT : KNEE TIBIAL TRAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 ATTUNE RP TIB BASE SZ 2 CEM; ATTUNE IMPLANT : KNEE TIBIAL TRAY Back to Search Results
Model Number 1506-10-002
Medical Device Problem Code Loss of or Failure to Bond (1068)
Health Effect - Clinical Codes Pain (1994); Ambulation or Postural Difficulties (2544); Swelling/ Edema (4577)
Date of Event 11/04/2020
Type of Reportable Event Serious Injury
Event or Problem Description
Patient received a left primary attune to treat djd.The patella was resurfaced and depuy cement x 2 was utilized.The procedure was completed without complications.Patient received a left knee revision to treat pain, swelling, and walking difficulty secondary to suspected tibial tray loosening.Upon entering the joint, the surgeon evacuated a mild effusion and pathology confirmed no infection.The tibial tray was grossly loose and debonded at the cement to implant interface and revised.The femoral component was well-fixed but revised to accommodate the revision knee.The patella was well-fixed and retained.There was no reported product problem with the revised tibial insert.The patient received a competitor construct.The procedure was completed without complications.Doi: (b)(6) 2017.Dor: (b)(6) 2020.Left knee.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Initial reporter occupation: lawyer.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).Investigation summary : no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Device history lot : the product investigation found no evidence suspecting an error in the manufacturing or material that would be a contributing factor in the reported allegation(s).A manufacturing records evaluation (mre) was not performed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE RP TIB BASE SZ 2 CEM
Common Device Name
ATTUNE IMPLANT : KNEE TIBIAL TRAY
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
Manufacturer (Section G)
DEPUY IRELAND 9616671
loughbeg, ringaskiddy co.
cork
EI  
Manufacturer Contact
kate karberg
700 orthopaedic dr.
warsaw, IN 46581-0988
3035526892
MDR Report Key14914591
Report Number1818910-2022-12268
Device Sequence Number13945592
Product Code NJL
UDI-Device Identifier10603295042563
UDI-Public10603295042563
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P830055
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2020
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 07/05/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number1506-10-002
Device Catalogue Number150610002
Device Lot Number8399636
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/20/2022
Supplement Date Received by Manufacturer07/14/2022
Initial Report FDA Received Date07/05/2022
Supplement Report FDA Received Date07/15/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/16/2016
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ATTUNE CR FEM LT SZ 4 NAR CEM; ATTUNE CR RP INSRT SZ 4 6MM; ATTUNE MEDIAL ANAT PAT 32MM; ATTUNE RP TIB BASE SZ 2 CEM; SMARTSET GHV GENTAMICIN 40G; SMARTSET HV BONE CEMENT 40G
Outcome Attributed to Adverse Event Required Intervention;
Patient Age74 YR
Patient SexFemale
-
-